Cirrus Therapeutics, Inc. — Form D
Cirrus Therapeutics, Inc. of Cambridge, MA, a company, filed a Form D exempt-offering notice with the SEC on 2025-08-19. The offering totals $15.7M, of which $6.7M was reported sold. Industry: Other Technology.
Offering
- Filed: 2025-08-19
- Form: D
- Accession: 0002070295-25-000002
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $15.7M
- Amount sold: $6.7M
- Remaining: $9.0M
- Investors: 8
- Date of first sale: 2025-08-04
- Security types: equity
- Revenue range: Not Applicable
- SEC file number: 021-555163
Issuer
- Name: Cirrus Therapeutics, Inc.
- CIK: 0002078601
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 750 Main Street, Cambridge, MA, 02139
- Phone: (617) 959-3124
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Alexandra Cantley | Director | Newton, MA |
| Ying Kai Chan | Director | Cambridge, MA |
| Andrew Dick | Director | Cambridge, MA |
| Khoo Shih | Director | Cambridge, MA |
| Ying Kai Chan | Executive Officer | Cambridge, MA |
| Ying Kai Chan | Promoter | Cambridge, MA |
| Andrew Dick | Promoter | Cambridge, MA |
More